| CENTERS-FOR-DISEASE-CONTROL-AND-PREVENTION |
CENTERS-FOR-DISEASE-CONTROL-AND-PREVENTION |
90%
|
A portion of our revenues is derived from sales to customers that rely on funding from the U.S. government, including federal agencies, state programs, and entities receiving grants and contracts fro… |
| COMMERCIAL-CUSTOMER |
COMMERCIAL-CUSTOMER |
90%
|
Commercial customer (1) 14 % N/A |
| ENTITIES-RECEIVING-GRANTS-AND-CONTRACTS-FROM-THE |
ENTITIES-RECEIVING-GRANTS-AND-CONTRACTS-FROM-THE |
90%
|
A portion of our revenues is derived from sales to customers that rely on funding from the U.S. government, including federal agencies, state programs, and entities receiving grants and contracts fro… |
| FEDERAL-AGENCIES |
FEDERAL-AGENCIES |
90%
|
A portion of our revenues is derived from sales to customers that rely on funding from the U.S. government, including federal agencies, state programs, and entities receiving grants and contracts fro… |
| OTHER-GOVERNMENT-PROGRAMS |
OTHER-GOVERNMENT-PROGRAMS |
90%
|
A portion of our revenues is derived from sales to customers that rely on funding from the U.S. government, including federal agencies, state programs, and entities receiving grants and contracts fro… |
| STATE-PROGRAMS |
STATE-PROGRAMS |
90%
|
A portion of our revenues is derived from sales to customers that rely on funding from the U.S. government, including federal agencies, state programs, and entities receiving grants and contracts fro… |
| U-S-AGENCY-FOR-INTERNATIONAL-DEVELOPMENT |
U-S-AGENCY-FOR-INTERNATIONAL-DEVELOPMENT |
90%
|
A portion of our revenues is derived from sales to customers that rely on funding from the U.S. government, including federal agencies, state programs, and entities receiving grants and contracts fro… |
| STQN |
Strategic Acquisitions, Inc. |
72%
|
ments concerning the Company and its products or services, including with respect to significant acquisitions, strategic collaborations and joint ventures; • Ability to achieve the expected benefits,… |
| STQN |
Strategic Acquisitions, Inc. |
72%
|
Reciprocal relationship from STQN graph: Reciprocal relationship from OSUR graph: ments concerning the Company and its products or services, including with respect to significant acquisitions, strate… |
| TELA |
TELA Bio, Inc. |
72%
|
Reciprocal relationship from TELA graph: rgeon adoption of biologic and biosurgery technologies. Members of our team have held leading positions with medical technology companies such as Orthovita In… |
| DNA-GENOTEK-INC |
DNA-GENOTEK-INC |
62%
|
ncing activities ( 16,944 ) ( 4,176 ) ( 3,023 ) EFFECT OF FOREIGN EXCHANGE RATE CHANGES ON CASH 4,292 ( 6,816 ) 1,713 NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS ( 68,485 ) ( 22,644 ) 206,42… |
| DNA-GENOTEK-INC-SHERLOCK-BIOSCIENCES-INC |
DNA-GENOTEK-INC-SHERLOCK-BIOSCIENCES-INC |
62%
|
ics to connect people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its… |
| ORASURE-TECHNOLOGIES-INC |
ORASURE-TECHNOLOGIES-INC |
62%
|
the Company, our employees, and our customers from cybersecurity threats. This system, which is Table of Contents informed by the National Institute of Standards and Technology (NIST) Cybersecurity F… |
| SHERLOCK-BIOSCIENCES-INC |
SHERLOCK-BIOSCIENCES-INC |
62%
|
ncing activities ( 16,944 ) ( 4,176 ) ( 3,023 ) EFFECT OF FOREIGN EXCHANGE RATE CHANGES ON CASH 4,292 ( 6,816 ) 1,713 NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS ( 68,485 ) ( 22,644 ) 206,42… |
